U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Vaccine Development: Current Status and Future Needs: This report is based on a colloquium, sponsored by the American Academy of Microbiology, held March 4-6, 2005, in Washington, DC. Washington (DC): American Society for Microbiology; 2005. doi: 10.1128/AAMCol.4Mar.2005

Cover of Vaccine Development: Current Status and Future Needs

Vaccine Development: Current Status and Future Needs: This report is based on a colloquium, sponsored by the American Academy of Microbiology, held March 4-6, 2005, in Washington, DC.

Show details

TABLE 4.Vaccines removed from the market

VACCINECOMMENTS
SMALLPOXSMALLPOX ERADICATED
ORAL POLIO (OPV)POLIO REGIONALLY ELIMINATED
A SAFER VERSION (INACTIVATED POLIO VACCINE) WAS AVAILABLE THAT REPLACED THE LIVE ATTENUATED ORAL VACCINE IN INDUSTRIALIZED COUNTRIES
ROTAVIRUS (ROTASHIELD®)SAFETY CONCERNS (IMPLICATED AS A CAUSE OF INTUSSUSCEPTION IN INFANTS)
LYME DISEASESAFETY CONCERNS (REAL AND/OR PERCEIVED AUTOIMMUNE SIDE EFFECTS)
ECONOMIC REASONS (ACTUAL MARKET PROVED MUCH SMALLER THAN ORIGINALLY ANTICIPATED, EXPENSIVE LITIGATION)
ADENOVIRUSECONOMIC REASONS (THE COSTS OF ADHERING TO NEW GOOD MANUFACTURING PRACTICE RULES WERE PROHIBITIVE FOR THE MANUFACTURER)
HEPATITIS B (PLASMA-DERIVED)PERCEIVED SAFETY RISKS (HUMAN PLASMA WAS SEEN AS UNSAFE FOR VACCINE PRODUCTION IN THE WAKE OF THE DISCOVERY OF AIDS IN THE 1980S)
REPLACED BY AN IMPROVED PRODUCT (RECOMBINANT HBV VACCINE)
HBV RECOMBINANTSUSPENDED FROM USE IN SCHOOL-AGED CHILDREN IN FRANCE
PERCEIVED SAFETY RISKS (UNSUBSTANTIATED LINKS TO MULTIPLE SCLEROSIS)
WHOLE CELL PERTUSSISREMOVED FROM THE MARKET IN SWEDEN BECAUSE OF SAFETY CONCERNS (REPLACED IN OTHER MARKETS WITH THE ACELLULAR PERTUSSIS VACCINE)
KILLED MEASLESSAFETY CONCERNS (ATYPICAL MEASLES)
HIB POLYSACCHARIDEREPLACED BY AN IMPROVED PRODUCT (HIB CONJUGATE VACCINE)
NEURAL TISSUE-DERIVED RABIESREPLACED BY AN IMPROVED PRODUCT (CELL CULTURE-DERIVED VACCINE)
INTRANASAL INACTIVATED INFLUENZA (ADJUVANTED WITH WTLT)SAFETY CONCERNS (BELL'S PALSY)

Views

  • Cite this Page
  • PDF version of this title (1.1M)

Similar articles in PubMed

See reviews...See all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...